Mackenzie Financial
CRL icon

Mackenzie Financial’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$152M Sell
1,002,049
-902
-0.1% -$137K 0.2% 113
2025
Q1
$151M Buy
1,002,951
+25,878
+3% +$3.9M 0.21% 113
2024
Q4
$180M Buy
977,073
+5,805
+0.6% +$1.07M 0.25% 99
2024
Q3
$191M Buy
971,268
+42,108
+5% +$8.29M 0.27% 96
2024
Q2
$192M Sell
929,160
-2,637
-0.3% -$545K 0.29% 94
2024
Q1
$252M Buy
931,797
+13,939
+2% +$3.78M 0.36% 72
2023
Q4
$217M Sell
917,858
-5,791
-0.6% -$1.37M 0.33% 81
2023
Q3
$177M Buy
923,649
+4,507
+0.5% +$864K 0.3% 87
2023
Q2
$192M Buy
919,142
+53,032
+6% +$11.1M 0.29% 90
2023
Q1
$175M Buy
866,110
+65,534
+8% +$13.2M 0.27% 90
2022
Q4
$174M Buy
800,576
+89,751
+13% +$19.6M 0.29% 88
2022
Q3
$140M Sell
710,825
-276,409
-28% -$54.4M 0.24% 100
2022
Q2
$211M Buy
987,234
+131,020
+15% +$28M 0.34% 68
2022
Q1
$243M Buy
856,214
+553,121
+182% +$157M 0.33% 73
2021
Q4
$114M Sell
303,093
-3,820
-1% -$1.44M 0.15% 147
2021
Q3
$127M Sell
306,913
-140,543
-31% -$58M 0.18% 139
2021
Q2
$166M Buy
447,456
+185,667
+71% +$68.7M 0.23% 105
2021
Q1
$75.9M Sell
261,789
-167,554
-39% -$48.6M 0.12% 169
2020
Q4
$107M Buy
429,343
+60,774
+16% +$15.2M 0.23% 129
2020
Q3
$83.5M Buy
368,569
+2,863
+0.8% +$648K 0.21% 134
2020
Q2
$63.8M Buy
365,706
+104,445
+40% +$18.2M 0.17% 146
2020
Q1
$33M Buy
261,261
+6,683
+3% +$843K 0.11% 184
2019
Q4
$38.9M Buy
254,578
+69,400
+37% +$10.6M 0.1% 194
2019
Q3
$24.5M Buy
185,178
+183,382
+10,211% +$24.3M 0.06% 223
2019
Q2
$255K Sell
1,796
-27,388
-94% -$3.89M ﹤0.01% 988
2019
Q1
$4.24M Buy
+29,184
New +$4.24M 0.01% 577
2018
Q2
Sell
-719,731
Closed -$76.8M 1010
2018
Q1
$76.8M Sell
719,731
-351,447
-33% -$37.5M 0.2% 115
2017
Q4
$117M Buy
1,071,178
+142,382
+15% +$15.6M 0.28% 71
2017
Q3
$100M Buy
928,796
+417,739
+82% +$45.1M 0.54% 41
2017
Q2
$51.7M Buy
511,057
+49,557
+11% +$5.01M 0.29% 100
2017
Q1
$41.5M Hold
461,500
0.24% 115
2016
Q4
$35.2M Buy
461,500
+420,675
+1,030% +$32.1M 0.21% 131
2016
Q3
$3.4M Buy
40,825
+4,995
+14% +$416K 0.02% 285
2016
Q2
$2.95M Buy
+35,830
New +$2.95M 0.02% 375